October 6, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Current Article

Beyond biologics: Amgen bets new drugs will pay dividend

IN THIS ARTICLE

Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.